Tags anti-obesity market Novo Nordisk Bets $506M on Ireland Expansion to Counter Eli Lilly Competition businessx March 3, 2026 Danish pharmaceutical giant Novo Nordisk is investing €432 million ($506 million) in its Athlone facility in Ireland to expand production
